Literature DB >> 1848063

The region 0.7615-0.796 m.u. of the HSV-1 genome determines suppression of humoral antibody formation against herpes simplex virus.

K Wollert1, T el Ansari, A Rösen-Wolff, D Falke.   

Abstract

The influence of genetic properties of parts of the HSV-1 genome on suppression of humoral antibody formation was investigated by using intratypic recombinants. The deleted strain HFEM (HSV-1) induces suppression. The MluI DNA fragment (coordinates 0.7615-0.796 m.u.) derived from the antibody inducing strain F1 (HSV-1) was transfected into the deleted strain HFEM to produce the recombinant virus R-M1CI and shown to restore antibody formation, as demonstrated by neutralization- and ELISA-tests. The intratypic recombinant viruses R-15, R-19 and R-26, produced by transfection of the Bam HI DNA-fragment B (0.738-0.809 m.u.) of strain F1 into the deleted strain HFEM, resulted in antibody formation only in the recombinant virus R-26. The reason for these different properties might be associated with the presence of small deletions in the SmaI A-fragment (0.763-0.765 m.u.) or elsewhere in the Bam HI DNA-fragment B. Our results were finally correlated to replication of the recombinant viruses in macrophages and to spread into spleen and adrenal glands. There is evidence that antibody formation may be correlated to the ability of HSV to replicate in macrophages.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848063     DOI: 10.1007/bf01319240

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  19 in total

1.  Heterogeneity of BamHi DNA fragments B and E in several HSV-1 strains and recombinants.

Authors:  M Moyal; I Raibstein; A Rösen; G Darai; Y Becker
Journal:  Virus Genes       Date:  1988-03       Impact factor: 2.332

2.  In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine.

Authors:  K Deres; H Schild; K H Wiesmüller; G Jung; H G Rammensee
Journal:  Nature       Date:  1989-11-30       Impact factor: 49.962

3.  Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.

Authors:  P M Ejercito; E D Kieff; B Roizman
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

4.  DNA sequence and RNA transcription through a site of recombination in a non-neurovirulent herpes simplex virus intertypic recombinant.

Authors:  R L Thompson; G V Devi-Rao; E K Wagner
Journal:  Virus Genes       Date:  1988-06       Impact factor: 2.332

5.  Amplification of a short nucleotide sequence in the repeat units of defective herpes simplex virus type 1 Angelotti DNA.

Authors:  H C Kaerner; A Ott-Hartmann; R Schatten; C H Schröder; C P Gray
Journal:  J Virol       Date:  1981-07       Impact factor: 5.103

6.  Determination of the nucleotide sequence flanking the deletion (0.762 to 0.789 map units) in the genome of an intraperitoneally avirulent HSV-1 strain HFEM.

Authors:  H G Koch; A Rösen; F Ernst; Y Becker; G Darai
Journal:  Virus Res       Date:  1987-04       Impact factor: 3.303

7.  A sequence in HpaI-P fragment of herpes simplex virus-1 DNA determines intraperitoneal virulence in mice.

Authors:  Y Becker; J Hadar; E Tabor; T Ben-Hur; I Raibstein; A Rösen; G Darai
Journal:  Virology       Date:  1986-03       Impact factor: 3.616

8.  Herpes simplex virus type 1 and 2 in the adrenal glands: replication and histopathology.

Authors:  D Potratz; B Brake; H P Dienes; T F Schulz; M Hosp; M P Dierich; D Falke
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

9.  Suppression and enhancement of humoral antibody formation by herpes simplex virus types 1 and 2.

Authors:  S Nick; P Kampe; A Knoblich; B Metzger; D Falke
Journal:  J Gen Virol       Date:  1986-06       Impact factor: 3.891

10.  Characterization of RNA transcripts from herpes simplex virus-1 DNA fragment BamHI-B.

Authors:  T Ben-Hur; M Moyal; A Rösen-Wolff; G Darai; Y Becker
Journal:  Virology       Date:  1989-03       Impact factor: 3.616

View more
  2 in total

1.  Pathogenesis of HSV-1/2 induced vaginitis/vulvitis of the mouse: dependence of lesions on genetic properties of the virus and analysis of pathohistology.

Authors:  M Fleck; J Podlech; K Weise; H Müntefering; D Falke
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

2.  A vaccinia virus--herpes simplex virus (HSV) glycoprotein B1 recombinant or an HSV vaccine overcome the HSV type 2 induced humoral immunosuppression and protect against vaginal challenge in BALB/c mice.

Authors:  M Fleck; J Podlech; K Weise; D Falke
Journal:  Med Microbiol Immunol       Date:  1994-05       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.